Keith and Heather’s Story
Having lost his left lung to cancer, Keith faced a challenging road to recovery but didn’t allow it to limit his lifestyle or ambitions.
Search
Brightline-2 trial launch in biliary tract and pancreatic cancers
Find out more about the Brightline-2 trial and our commitment to people living with biliary tract and pancreatic cancers.
vaxxitek® hvt + ibd + nd
Bursal Disease-Marek's disease-Newcastle disease vaccine, serotype 3, live Marek's disease vector; the vaccine includes a diluent
Arti-Cell® FORTE
Arti-Cell® FORTE Used to treat mild to moderate lameness linked to non-infective joint inflammation in horses. It contains stem cells which are obtained from equine blood. Stem cells can develop into other types of cells. The stem cells in the active subs
Aservo® EquiHaler®
Aservo® EquiHaler®
Partnering Vanderbilt WCNDD
Boehringer Ingelheim and the Warren Center for Neuroscience Drug Discovery are partnering to find new medicines for patients with neuropsychiatric disorders.
Advice to Fellow Patients
People living with cancer share their advice for fellow patients, from checking information sources to living in the present moment.
Mental Health
Hear the perspectives of people living with cancer on the topic of mental health.
Contact Us
Contact Us Thank You page
Behind the Lab
Delve behind the lab to see how our Retinal Health scientists are spearheading research into novel therapeutics to treat retinopathies.
Mechanistic Modeling in Biotherapeutic Drug Development
Mechanistic modeling is revolutionizing biotherapeutic drug development with the goal of getting new medicines to patients faster, more reliably and more cost-effectively.
Bernard Mental Health Impact
Harold and Friends learn about how living with multiple health conditions can impact mental health
Annual Results Press Conference 2022
Boehringer Ingelheim presents the results of business development and gives an outlook for the coming year.
Sifrol®
Symptomatic treatment of idiopathic Parkinson’s disease. It may be used as monotherapy or in combination with levodopa. Symptomatic treatment of idiopathic moderate to severe restless legs syndrome.
MicardisPlus®
US: Treatment of hypertension alone or with other antihypertensive agents, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Not indicated for
Heart Failure
Heart Failure
Clinical Collaborations
Clinical Collaborations
Research Collaborations
Research Collaborations
Facts About Asthma
Facts About Asthma
Trust Through Transparency
Trust Through Transparency
EFPIA disclosure
.
Living Independence
Boehringer Ingelheim’s corporate culture is based on values that have been applied since the company was founded in 1885.
OUR FOCUS
Our FOCUS is the cultural framework for our company. It describes who we are and what we strive for, why we exist, how we work and what we want to achieve.
The Angels Initiative – F.A.S.T.
The Angels initiative, stroke symptoms, giving life a chance, optimizing stroke care
BI Access to Healthcare Strategy_Availability
Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.